Private Label Peptide Zinc Niacinamide Acne Serum Manufacturer

The honest answer is that MOQ depends almost entirely on the production route you choose, and ranges vary more than most directories admit. For a white-label or stock-base serum—where the manufacturer already has a validated niacinamide-zinc-peptide formula on the shelf and simply fills it into your branded packaging—MOQs typically start at 100 to 300 units. This is the fastest, lowest-risk entry point, and many independent founders use it to validate demand before committing to a custom formula. For semi-custom work—where you adjust the concentration of one or two actives, change the scent, or modify the texture—most contract manufacturers require 300 to 1,000 units. The higher floor exists because the formulator must run small-batch benchtop trials, stability checks, and potentially re-do micro testing before signing off on a modified formula. For fully custom development from your own brief—meaning the cosmetic chemist builds the formula to your specification with a defined peptide stack, exact niacinamide percentage, and a preservation system you specify—expect MOQs of 500 to 2,000 units. At this level you'll also negotiate IP ownership and receive a formula card you legally own. Several factors can lower the stated MOQ. Supplying your own packaging (bottles, pumps, caps) removes the manufacturer's component inventory risk and is the single most effective negotiating lever. Agreeing to a longer lead time—letting the manufacturer schedule your batch alongside a larger run—can also reduce minimums by 20 to 30%. A flexible fill date during a manufacturer's quiet season is valuable to them. Factors that push MOQ higher include certified-organic or Cosmos-compliant actives (supplier minimum buys are larger), complex preservative systems requiring extended challenge testing, and export to regulated markets like the EU where additional documentation must be produced per batch. A common mistake first-time founders make is negotiating MOQ down to the absolute minimum without modelling cost-per-unit. At 100 units your cost might be $14 per unit; at 500 units the same formula from the same manufacturer might drop to $8. If your retail price is $35, the difference between a 40% and 77% gross margin at launch is significant. AJ Cosmo Labs lets you filter manufacturers by MOQ inside the app, so you can see at a glance which suppliers can serve a 150-unit launch before you even send an enquiry.

Total landed cost has three buckets: formula development (a one-time NRE), per-unit manufacturing, and packaging. You need to account for all three before you build a margin model. Formula development fees (NRE — non-recurring engineering) for a custom actives serum typically run $500 to $3,500 depending on the complexity of the peptide stack and the number of revision rounds. Some manufacturers waive this fee once you hit a volume threshold (commonly 1,000 units total over 12 months), so always ask upfront whether the NRE is waived or credited against your first production run. Per-unit manufacturing cost (formula + filling, not including packaging) for a niacinamide-zinc-peptide serum generally falls into these bands: — Stock/white-label formula, 100–300 units: $4–$8 per unit — Semi-custom, 300–1,000 units: $7–$12 per unit — Fully custom, 500–2,000 units: $10–$18 per unit — Cosmos-certified or clean-standard custom: $14–$22 per unit What drives per-unit cost upward: higher peptide concentrations (GHK-Cu and palmitoyl tripeptide-1 are expensive raw materials), low-VOC or naturally derived solubilisers, airless pump packaging (which has a higher component cost than a dropper), and small run size. Packaging adds $1–$6 per unit depending on the vessel. A 30ml frosted glass dropper with a screen-printed label runs approximately $1.50–$2.50 per unit at 500 pieces. An airless pump in the same quantity runs $2.50–$4.50. Secondary carton packaging adds $0.40–$1.20 per unit. Third-party certifications—dermatologist-tested claims, non-comedogenic panel testing, or consumer perception studies—typically cost $1,500–$6,000 as flat project fees, not per-unit costs. A realistic all-in cost for a 500-unit semi-custom launch in glass dropper packaging, without NRE (waived at volume), without third-party claims testing, is approximately $12–$16 per unit landed. At a $42 retail price that yields 62–71% gross margin before DTC fulfillment and marketing. When you post a brief on AJ Cosmo Labs, manufacturers quote against your actual specification, so the figures above become real competing bids rather than estimates.

The lead time question is the one founders most consistently underestimate, and it's responsible for more missed launch windows than any other single factor. If you choose a stock or white-label base formula that the manufacturer already has validated and on the shelf, total lead time—from signed agreement to product in your hands—is typically 4 to 8 weeks. The bulk of that time is packaging sourcing, label printing, and quality control release, not formula work. For semi-custom work, where actives concentrations are adjusted or a new fragrance is introduced, add 6 to 8 weeks for benchtop reformulation, a minimum stability read (typically T0 and T4-week accelerated), and micro challenge testing. Total timeline: 10 to 16 weeks. For fully custom development, the stage-by-stage breakdown typically looks like this: — Weeks 1–2: NDA, brief alignment, raw material sourcing list confirmed — Weeks 3–6: Benchtop formulation iterations (2–4 rounds of samples) — Weeks 7–10: Accelerated stability initiation; challenge test; founder sample approval — Weeks 11–14: Packaging compatibility testing (actives can interact with certain pump mechanisms and coatings); label artwork and regulatory review — Weeks 15–20: Production batch scheduling, manufacture, QC release — Weeks 20–24: Shipping and inbound logistics If you need third-party dermatologist testing, consumer panel studies, or a non-comedogenic certification to support marketing claims, budget an additional 4 to 6 weeks after the production batch is released, because these studies require product in final packaging. For EU export, preparing a Product Information File (PIF) and completing CPNP notification can add 2 to 4 weeks if the manufacturer's regulatory team is doing it for you, or longer if you use a third-party EU responsible person. The most common first-timer mistake is booking PR, influencer seeding, or a trade show appearance 8 weeks after signing a contract for custom development. Plan for 20–24 weeks minimum for a bespoke peptide-zinc-niacinamide serum and build a 4-week buffer on top of that.

Certifications matter both for regulatory compliance and for the marketing claims you'll be able to make on product pages and in DTC advertising. The relevant credentials fall into two categories: manufacturer certifications and product certifications. For the manufacturer itself, the baseline expectation in the US market is cGMP (current Good Manufacturing Practices) compliance. Under MoCRA (the Modernization of Cosmetics Regulation Act, effective December 2023), cosmetic manufacturers must now register their facilities with the FDA and submit ingredient listings. Confirm your manufacturer is registered or in the process of registering. ISO 22716 is the internationally recognised GMP standard for cosmetics and is mandatory if you intend to export to the EU, UK, Australia, or Canada. For the product, the certifications you may want to support are: — Cruelty-free: Leaping Bunny (most rigorous, recognised in EU and UK) or PETA's Beauty Without Bunnies. These require the manufacturer and their raw material suppliers to complete questionnaires and audits. — Vegan: Usually self-declared or certified through the Vegan Society or BeVeg. Confirm no animal-derived actives (some peptides are marine-derived). — Cosmos Organic or Cosmos Natural: The European standard for organic and natural cosmetics, run by Ecocert, BDIH, Cosmebio, ICEA, and the Soil Association. This is the hardest to achieve and requires that actives and preservatives meet permitted ingredient lists—which eliminates several common synthetic peptides. — NSF/ANSI 305: US standard for personal care products containing organic ingredients. Less globally recognised than Cosmos. — Non-comedogenic: Not a standardised certification, but a consumer claim. Supported either by a dermatologist review of the formula or a formal comedogenicity panel (in vivo or in vitro). — Dermatologist tested: A claim backed by a third-party clinical study. Requires a recruited panel and a protocol, typically 20–30 subjects minimum for a basic tolerance study. For an acne-positioned serum, the most commercially valuable certifications are cruelty-free, vegan, and non-comedogenic—in that order for DTC skincare audiences. ISO 22716 manufacturer compliance is non-negotiable for EU export. Ask any manufacturer you shortlist on AJ Cosmo Labs to share their ISO 22716 certificate and FDA facility registration number before you sign anything.

Formula ownership is one of the most misunderstood commercial terms in private label cosmetics, and getting it wrong can trap your brand with a single supplier indefinitely. In a white-label or stock-formula arrangement, you do not own the formula. The manufacturer owns it. You are licensing the right to sell product made to their specification. If you switch manufacturers—or if they discontinue the formula—you start from scratch. This is commercially acceptable at launch if you're validating a concept, but it is not a defensible position for a brand building long-term equity. In a custom development arrangement, formula ownership depends entirely on what you negotiate in the contract before work begins. The default legal position in most jurisdictions is that the manufacturer who creates the formula owns the intellectual property unless the contract explicitly transfers it to you. Never assume. The contract must include a clear IP assignment clause that transfers ownership of the formula, the INCI list, and the manufacturing process notes to your company upon payment. A signed NDA (non-disclosure agreement) is the prerequisite. It prevents the manufacturer from sharing your formula with competitors or using it for other clients. NDAs and IP transfer agreements are separate documents—an NDA alone does not give you ownership. The formula card you receive should include: INCI ingredient list, precise percentages or concentration ranges for each ingredient, processing instructions (pH targets, temperature profiles, mixing sequence), and batch testing parameters. With this document, a second qualified manufacturer should be able to replicate your product independently. Note that some manufacturers will negotiate a compromise: they retain the base formula architecture but assign you the rights to the specific concentration profile and actives stack you developed with them. This is sometimes called a semi-proprietary arrangement and is more common when the NRE fee is waived. For a peptide-zinc-niacinamide serum where the actives combination is a meaningful differentiator, full IP transfer with the formula card is worth paying NRE for upfront. Use AJ Cosmo Labs to message manufacturers directly about their IP policy before you invest time in a scoping call.

Cosmetic serums containing niacinamide and zinc—sold with claims like 'balances sebum,' 'minimises pores,' or 'reduces redness'—are regulated as cosmetics under FDA jurisdiction. The key distinction to understand is that if you make drug claims such as 'treats acne,' 'kills acne-causing bacteria,' or 'clinically proven to reduce acne lesions,' your product is reclassified as an OTC drug and must comply with the FDA OTC Drug Monograph for acne (which permits only specific active ingredients like benzoyl peroxide, salicylic acid, and adapalene, at defined concentrations). Peptides and zinc PCA do not appear in the OTC acne monograph, so they cannot support drug-level acne claims regardless of their efficacy data. For a cosmetic positioned with skin-tone, pore, and sebum-balancing language—the safe and common positioning for this formula—the current US regulatory framework post-MoCRA (December 2023) requires: 1. FDA facility registration: Your contract manufacturer must register their facility with the FDA Cosmetic Facility Registration system. This is now mandatory, not voluntary. 2. Ingredient listing submission: Manufacturers must submit ingredient listings to the FDA. If your contract manufacturer is handling production, this is their obligation, but you should confirm it is being met. 3. Responsible person: Under MoCRA, a 'responsible person'—typically the brand owner or the US importer—must ensure the product is safe and properly labeled. This is you, as the brand. 4. INCI labeling: Your label must list all ingredients in descending order of concentration using INCI nomenclature, exactly as required under 21 CFR 701.3. Niacinamide is listed as 'Niacinamide,' zinc PCA as 'Zinc PCA,' and peptides under their INCI names (e.g., Palmitoyl Tripeptide-1, Acetyl Hexapeptide-3). 5. Safety substantiation: You must be able to substantiate that your product is safe. A safety assessment from a qualified cosmetic chemist or toxicologist, accompanied by stability data and a passing challenge test, constitutes standard substantiation. For California specifically, Prop 65 requires a warning if any listed chemical is present above threshold concentrations. Most properly formulated serums do not trigger this, but confirm with your formulator. For EU or UK export, the regulatory burden is significantly higher: a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor, a Product Information File (PIF), CPNP notification (EU) or SCPN notification (UK), and a named responsible person domiciled in the EU or UK are all required before you can place the product on those markets.

Finding a manufacturer is not the hard part—there are thousands of cosmetic contract manufacturers globally. Finding one that is actually qualified to handle a multi-active serum at a low MOQ, is willing to do an IP transfer, has ISO 22716 certification, and will respond to a small brand in a timely manner—that is the hard part. The conventional approaches each have significant drawbacks. Trade shows like Cosmoprof or NYSCC Suppliers' Day give you face time with sales reps, but you'll spend thousands in travel for a 5-minute conversation that leads to a 6-week proposal turnaround. Cold emailing manufacturers from public directories produces a 10 to 20% response rate at best, and most directories have outdated contact information or no vetting of capabilities. Referrals from other founders are high quality but slow to collect and geographically biased. A structured digital platform built for this sourcing problem is the most efficient route for founders working with low-MOQ constraints. AJ Cosmo Labs was built specifically for this: post a brief describing your peptide zinc niacinamide acne serum project—including your target MOQ, actives stack, certifications needed, and timeline—and receive responses from cosmetic manufacturers and cosmetic chemists who have opted into the platform and confirmed they serve small-to-mid-size brands. When evaluating any manufacturer you connect with, request the following before signing: — ISO 22716 certificate and expiry date — FDA facility registration confirmation (post-MoCRA) — A sample stability report from a comparable actives serum (niacinamide or peptide-containing) — Their IP policy in writing (do they transfer formula ownership?) — References from two brands they've manufactured for at a similar MOQ — Their minimum batch size in kilograms or litres, not just units (this tells you the real floor) Disqualify any manufacturer that cannot provide a passing micro challenge test result for a comparable formula, refuses to share their quality documentation, or is unwilling to execute an NDA before the scoping call. Download the AJ Cosmo Labs iOS app from the App Store, post your project brief, and start collecting qualified bids—it takes less time than building a manufacturer shortlist from scratch.